Edesa Biotech Inc

EDSA NASDAQ
4.020
-0.010
-0.25%
Opening 11:47 08/21 EDT
Open
4.080
Prev Close
4.030
High
4.080
Low
4.010
Volume
2.48K
Avg Vol (3M)
1.09M
52 Week High
17.40
52 Week Low
3.590
% Turnover
0.03%
Market Cap
30.17M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Edesa Biotech Inc EDSA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Edesa Biotech Inc., Stellar Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for dermatological and gastrointestinal indications. The Company’s lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis. The Company has its operations in the United States and in Canada.
MORE >

Recently

Name
Price
%Change